#AUA14 - Poster: Overactive bladder patients ‚Č• 65 years of age have a similar efficacy and safety profile with onabotulinumtoxinA as patients less than 65 years of age

ORLANDO, FL USA (UroToday.com) - Presented by Courtenay Moore,1 Albert Kaufmann,2 Manher Joshi,3 Christopher Nardo,3 Yan Zheng,4 and Sender Herschorn5 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

aua 2014 moore age poster thumb

1Cleveland Clinic, Cleveland, OH, USA; 2Kliniken Maria Hilf GmbH, Mönchengladbach, Germany; 3Allergan, Inc., Irvine, CA, USA; 4Allergan, Inc., Bridgewater, NJ, USA; 5University of Toronto, Toronto, ON, Canada